Medscape16h
Support for Omitting SLNB in Some Early Breast Cancers
Results of the INSEMA trial indicated that it’s safe to omit axillary sentinel lymph node biopsy in patients with clinically ...
SABCS: Omission of axillary staging noninferior for node-negative breast cancer
Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically node-negative ...
Medpage Today on MSN22h
No Apparent Harm From Omitting Lymph Node Dissection in Selected Breast Cancers
Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent ...
Cancer Therapy Advisor9h
SLNB Can Be Omitted in Early Invasive Breast Cancer, Data Suggest
Omitting axillary SLNB does not impact outcomes in patients with early invasive breast cancer undergoing breast-conserving surgery, data suggest.